300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Mobile Apps
Cannabis
LGBT
Celebrity
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Wine and Spirits
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Food and Beverage
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Publishing
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Bangladesh
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device Startup Investors in Israel (August 2026)

The most active venture capital funds and angel investors investing in Israel Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Israel Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Israel Innovation Authority
VC Fund
10 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $130k–$5M
Trendlines Group
VC Fund
8 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $650k–$15M
Pontifax
VC Fund
8 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6.3M–$130M
Maccabi Fund
VC Fund
6 Israel, United States Seed, Series A, Grant Health Care, Artificial Intelligence, Medical Device $1.5M–$15M
Accelmed
VC Fund
5 United States, Israel Series D, Series A Health Care, Medical Device, Medical $695k–$96M
OurCrowd
VC Fund
5 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $593k–$65M
Agriline
VC Fund
5 Israel Seed, Series A, Venture - Series Unknown Health Care, Medical, Medical Device $1.3M–$17M
J-Ventures
VC Fund
4 United States, Israel Series A, Seed, Pre-Seed Software, Health Care, Machine Learning $3M–$27M
Btomorrow Ventures
VC Fund
4 United States, United Kingdom, India Series A, Seed, Series B Health Care, Wellness, Food and Beverage
Elron Ventures
VC Fund
4 Israel, United States, China Seed, Series A Information Technology, Software, Cyber Security $1M–$17M
Longevity Venture Partners
VC Fund
4 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Health Care, Medical Device, Health Diagnostics $1.2M–$11M
Magma Venture Partners
VC Fund
3 Israel, United States, Mexico Series A, Series B, Seed Software, Mobile, Enterprise Software $800k–$30M
Access Medical Ventures
VC Fund
3 Israel Series A, Series D Health Care, Manufacturing, Medical Device
Iron Nation
VC Fund
3 Israel, United States, Germany Seed, Series A, Series B Health Care, Artificial Intelligence, Software $850k–$20M
OTV
VC Fund
3 United States, Israel, Ghana Series A, Series B, Seed Health Care, Medical, Medical Device $5M–$50M
Shimon Eckhouse
Angel
3 Israel Series A, Series B, Series C Health Care, Medical Device, Medical
ALIVE Israel HealthTech Fund
VC Fund
3 Israel, United States Series A, Series C, Series B Health Care, Medical, Medical Device $4.4M–$55M
MTIP AG
VC Fund
3 United States, United Kingdom, Spain Series A, Series B, Series C Health Care, Medical, Artificial Intelligence $1.5M–$80M
Robin Hood Ventures
VC Fund
3 United States, Canada, Israel Seed, Series A Software, Health Care, Biotechnology $100k–$11M
Consensus Business Group
VC Fund
3 Israel, United States, United Kingdom Seed, Series A Health Care, Medical Device, Medical $1M–$10M
Rimonci Capital
VC Fund
3 Israel, France, United States Series A, Seed, Series B Health Care, Medical Device, Eyewear $3.6M–$11M
XT Venture Capital
VC Fund
3 Israel, Singapore, United States Series A, Seed, Series B Software, Health Care, Travel $3.2M–$100M
Docor International Management
VC Fund
3 Israel, United States Series C, Series A Health Care, Biotechnology, 3D Technology $13M–$22M
OrbiMed
VC Fund
3 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$183M
Rapha Capital Management
VC Fund
3 United States, Israel Series A, Series C, Post-IPO Debt Health Care, Therapeutics, Biotechnology $3M–$35M
Sofinnova Partners
VC Fund
3 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
Triventures
VC Fund
3 United States, Israel, Ireland Series A, Series B Health Care, Medical Device, Medical $6M–$28M
Israel Biotech Fund
VC Fund
3 Israel, United States Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $9M–$45M
Danny Hadar
Angel
2 Israel, United States Seed, Series B Software, Artificial Intelligence, Internet $65k–$11M
Impact First Investments
VC Fund
2 Israel, United States Seed, Series A Health Care, mHealth, Medical Device $500k–$8M
TechWald Holding S.p.A.
VC Fund
2 Israel, United States, Switzerland Series A, Series B, Series C Health Care, Medical Device, Medical $3.6M–$60M
Connecticut Innovations
VC Fund
2 United States, Israel, Canada Seed, Series A Health Care, Biotechnology, Software $300k–$25M
Smith & Nephew
VC Fund
2 United States, Israel, United Kingdom Series B, Series C Medical Device, Medical, Health Care $2.7M–$30M
Italian Angels for Growth
VC Fund
2 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care $219k–$14M
Eclipse
VC Fund
2 United States, Canada, Israel Series A, Series B, Seed Software, Robotics, Artificial Intelligence $2.3M–$100M
Clal Biotechnology Industries
VC Fund
2 Israel, United States Series A, Series B Health Care, Biotechnology, Medical Device $4M–$55M
ZORA Ventures
VC Fund
2 Israel, United States, United Kingdom Seed, Series A, Convertible Note Biotechnology, Health Care, Food and Beverage $1M–$8.6M
Emerge Ventures
VC Fund
2 Israel, United States Seed, Series A, Series B Software, Artificial Intelligence, SaaS $2.5M–$80M
Zohar Gilon
Angel
2 Israel, United States Seed, Series A, Series B Software, Internet, Health Care $1.5M–$15M
GlenRock Israel
VC Fund
2 Israel, United States Seed, Series A, Series B Software, Health Care, Cyber Security $100k–$30M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
2 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
Boston Scientific
VC Fund
2 United States, Israel, Canada Series B, Series C, Series D Health Care, Medical Device, Biotechnology $3M–$175M
Indaco Venture Partners
VC Fund
2 Italy, United States, United Kingdom Series A, Series B Biotechnology, Health Care, Medical
The Chartered Group
VC Fund
2 Israel Series A, Private Equity Biopharma, Agriculture, Health Care
Arkin Holdings
VC Fund
2 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$95M
Dov Moran
Angel
2 Israel, United States Series A, Seed, Series B Semiconductor, Hardware, Health Care
Terra Venture Partners
VC Fund
2 Israel, United States Seed, Series A, Series B Software, Machine Learning, Artificial Intelligence $1M–$30M
Laborie Medical Technologies
VC Fund
2 United States, Israel Series A, Venture - Series Unknown Health Care, Medical, Medical Device $11M–$32M
Merz Therapeutics
VC Fund
2 Israel Corporate Round, Venture - Series Unknown Health Care, Therapeutics, Medical Device
Chartered Opus
VC Fund
2 Israel Series A Wellness, Biotechnology, Manufacturing $3M–$3.5M
Access all 541 investors in Israel Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 10 investments in Israel Medical Device startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 200
  • Round size: Seed $500k–$5M; Grant $130k–$3.5M; Pre-Seed $150k–$2.1M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
  • GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Show all investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 8 investments in Israel Medical Device startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 8 investments in Israel Medical Device startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 117
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $12M–$101M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Maccabi Fund
VC Fund · 6 investments in Israel Medical Device startups

Maccabi Fund is an investment fund.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical Device
  • Stage:Seed, Series A, Grant
  • Geography: Israel, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $1.5M–$6.7M; Series A $1.5M–$15M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient's risk of having coronary artery diseasethrough advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
  • Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.
  • Rhino Federated Computing — Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing.
Show all investments...

Accelmed
VC Fund · Aventura, Florida, United States · 5 investments in Israel Medical Device startups

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 41
  • Round size: Series A $695k–$24M; Series D $13M–$96M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
  • UltraClear — UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
  • GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 5 investments in Israel Medical Device startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 309
  • Round size: Seed $593k–$10M; Series A $5.3M–$34M; Series B $8M–$65M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
  • MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Show all investments...

Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 5 investments in Israel Medical Device startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

J-Ventures
VC Fund · Palo Alto, California, United States · 4 investments in Israel Medical Device startups

J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.

Show more...

Investment focus

  • Industry: Software, Health Care, Machine Learning
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, Israel

Investor stats

  • Total investments: 76
  • Round size: Seed $3M–$7.2M; Series A $8M–$27M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely still investing — raised $32M in 2023

Portfolio highlights

  • Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Show all investments...

Btomorrow Ventures
VC Fund · London, England, United Kingdom · 4 investments in Israel Medical Device startups, 6 in the past 12 months

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 44
  • Lead/follow: no public data

Portfolio highlights

  • Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
  • Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
  • PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Show all investments...

Elron Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Medical Device startups

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Show more...

Investment focus

  • Industry: Information Technology, Software, Cyber Security
  • Stage:Seed, Series A
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 65
  • Round size: Seed $1.5M–$15M; Series A $1M–$17M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
  • Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
  • Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Longevity Venture Partners
VC Fund · Jerusalem, Yerushalayim, Israel · 4 investments in Israel Medical Device startups

Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $4M–$11M; Pre-Seed $1.2M–$3.6M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • CustoMED — End-to-end platform turning medical scans into patient-specific surgical plans, tools & implants instantly. AI-powered surgical planning in minutes.
  • Sensifai Health — Powered by insights from wearables, Sensifai alerts inflammatory flares before symptoms enabling true early intervention.
  • Urologic Health — Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
Show all investments...

Magma Venture Partners
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Magma is Israel's leading venture capital firm specializing in early-stage investments in communication, semiconductors, internet and media. They seek bright ideas, infuse them with experience and foresight, and facilitate their rise as industry leaders that redefine the global communications sector. They use their experience and sectorspecialization in cooperating with entrepreneurs, industry experts, and other investors to define the future of the communication, semiconductors, internet and media arenas. Their goal is to foster and enable the flow of innovation from an idea's early stages and through a company's emergence as a leader within its dynamic market. They understand the local market and help to influence the global one.

Show more...

Investment focus

  • Industry: Software, Mobile, Enterprise Software
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Mexico

Investor stats

  • Total investments: 118
  • Round size: Seed $800k–$6M; Series A $1.9M–$12M; Series B $6M–$30M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $24M in 2017

Portfolio highlights

  • Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
  • PayKey — The PayKey social banking and mobile P2P payment solution: A patent-pending mobile payment keyboard that seamlessly integrates with your banking application and lets users complete a transaction without leaving their social application.
  • Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
Show all investments...

Access Medical Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Access Medical Ventures is a U.S based venture capital fund that focuses specifically on investing and advancing medical device start-ups.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Medical Device
  • Stage:Series A, Series D
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • CartiHeal — CartiHeal, a privately held medical device company headquartered in Israel, is a pioneer in the field of cartilage regeneration. Cartilage injuries affect millions of patients around the world, and characteristically cause severe pain and disability. Hyaline cartilage has a very limited ability to heal once damaged. Research indicates that injuriesto joint cartilage, if left untreated, may lead to progressive joint changes and early onset of osteoarthritis. The need for a simple, well-tolerated and effective solution for cartilage repair and regeneration represents one of medicine’s most challenging unmet needs. CartiHeal's flagship Agili-C™ implant represents a significant medical breakthrough. This implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. The cell-free implant is inserted arthroscopically or via a minimally-invasive approach.
Show all investments...

Iron Nation
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Iron Nation support Israeli startups financially during a time of terror, helping them survive, their teams keep their jobs, and their company's growth trajectory.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 22
  • Round size: Seed $850k–$20M; Series A $3.9M–$6.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Ballerine — Ballerine helps financial services compose verification processes for any vertical and geography using modular building blocks, components, and 3rd party integrations.
  • Line 5 — Redefining autonomous defense
Show all investments...

OTV
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, Ghana

Investor stats

  • Total investments: 22
  • Round size: Seed $5M–$8M; Series A $6M–$12M; Series B $16M–$50M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — raised $170M in 2020

Portfolio highlights

  • TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
  • Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
  • Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Show all investments...

Shimon Eckhouse
Angel · 3 investments in Israel Medical Device startups

Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • SofWave Medical — Sofwave created a breakthrough in ultrasound technology developed by a team of veterans in the ultrasound and aesthetic medical industry . their purely non-invasive skin tightening treatment platform combines multiple proprietary innovations in ultrasound technology for highly-effective skin tightening results with unprecedented safety and zeropatient down time
  • Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
  • RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series C, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Show all investments...

MTIP AG
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Israel Medical Device startups

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Show more...

Investment focus

  • Industry: Health Care, Medical, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 28
  • Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
  • Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Show all investments...

Robin Hood Ventures
VC Fund · Philadelphia, Pennsylvania, United States · 3 investments in Israel Medical Device startups

Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 161
  • Round size: Seed $210k–$4.3M; Series A $100k–$11M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
  • Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
  • Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
Show all investments...

Consensus Business Group
VC Fund · London, England, United Kingdom · 3 investments in Israel Medical Device startups

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 23
  • Round size: Seed $1.3M–$4.5M; Series A $1M–$10M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Rimonci Capital
VC Fund · Beijing, Beijing, China · 3 investments in Israel Medical Device startups

A dedicated to China-Israel cross border investment.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Eyewear
  • Stage:Series A, Seed, Series B
  • Geography: Israel, France, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $3.6M–$3.6M; Series A $6.6M–$11M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • TECLens — TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore.
  • Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).
  • NovaSight — NovaSight brings together the power of eye tracking and Data Analytics, to revolutionize pediatric vision care.
Show all investments...

XT Venture Capital
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Established in 1997 as the venture arm of XT Holdings, XT Hi-Tech is one of the early investors in Israeli startups. Since inception, we have invested in over 80 companies in various technology categories and at different stages, including Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis.

Show more...

Investment focus

  • Industry: Software, Health Care, Travel
  • Stage:Series A, Seed, Series B
  • Geography: Israel, Singapore, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $3.2M–$7.4M; Series A $6M–$35M; Series B $20M–$100M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Duve — Give your guests the guest experience they deserve with Duve's guest experience platform for hotels, vacation rentals, hostels and more
  • SofWave Medical — Sofwave created a breakthrough in ultrasound technology developed by a team of veterans in the ultrasound and aesthetic medical industry . their purely non-invasive skin tightening treatment platform combines multiple proprietary innovations in ultrasound technology for highly-effective skin tightening results with unprecedented safety and zeropatient down time
  • ORION Security — ORION detects and prevents data loss across SaaS, email, cloud, AI tools, and endpoints using intelligent, context-aware, proprietary AI agents.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, 3D Technology
  • Stage:Series C, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series C $13M–$22M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 3 investments in Israel Medical Device startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 653
  • Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

Rapha Capital Management
VC Fund · Florida, New York, United States · 3 investments in Israel Medical Device startups

Rapha Capital Management focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value. For inquiries, telephone and contact details are used.

Show more...

Investment focus

  • Industry: Health Care, Therapeutics, Biotechnology
  • Stage:Series A, Series C, Post-IPO Debt
  • Geography: United States, Israel

Investor stats

  • Total investments: 10
  • Round size: Series A $5.3M–$35M; Post-IPO Debt $3M–$7.3M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Pulmatrix — Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaledanti-fungal for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSE™, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by achieving optimal local drug concentrations and reducing systemic side effects to improve patient outcomes.
  • FIZE Medical — FIZE Medical offers the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter. Learn more about us >>
  • AsclepiX Therapeutics — AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to designlong-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body.AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in Israel Medical Device startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 329
  • Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
Show all investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Israel Medical Device startups

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 60
  • Round size: Series A $6M–$24M; Series B $6M–$28M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • TailorMed — Moving Mountains for Patients
Show all investments...

Israel Biotech Fund
VC Fund · Rehovot, HaMerkaz, Israel · 3 investments in Israel Medical Device startups

Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $9M–$25M; Series B $17M–$30M; Series C $19M–$45M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — raised $65M in 2019

Portfolio highlights

  • Ukko — Our mission is to improve the lives of the millions that suffer from food allergies and gluten-related disorders
  • Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
  • Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Show all investments...

Danny Hadar
Angel · 2 investments in Israel Medical Device startups

For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Seed, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $65k–$11M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
  • Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
  • Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
Show all investments...

Impact First Investments
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

Impact First Investments is the first Israeli impact venture capital fund with the trifold aim to bolster Israeli technology, to build global social impact, and to obtain market-rate returns.Impact investing is dynamic. It’s a web of enterprise, venture, and ingenuity with the goal to do good and do well. At Impact First, they capitalize onboldness.Technology has the ability to both address challenges and scale solutions. They capitalize and advance this interest. They recognize this growing potential of doing good and doing well, and combined with experience in Israeli high tech, they have the ability to address global social challenges by supporting social tech startups.

Show more...

Investment focus

  • Industry: Health Care, mHealth, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 5
  • Round size: Seed $500k–$8M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • MyndYou — The Care Orchestration Platform that unites healthcare.
  • EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
  • General Galactic — General Galactic revolutionize the energy supply chain by producing synthetic hydrocarbons from air and waste CO2 using renewable electricity, making clean fuel affordable and accessible. General Galactic is developing technology to enable democratization of access to critical fuels at the site of need through modular hardware.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
TechWald Holding S.p.A.
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical Device startups

TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Series A $3.6M–$7.1M; Series B $8.5M–$48M; Series C $9.3M–$60M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
  • RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 2 investments in Israel Medical Device startups

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 267
  • Round size: Seed $300k–$6M; Series A $2.4M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $50M in 2023

Portfolio highlights

  • eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
  • Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
  • LegiTime Technologies — LegiTime Technologies, Inc. provides LegiText, a subscription-based SMS solution that offers message authentication, categorization, and archiving based on demonstration of legitimacy technology. It also provides LegiTrac that locates and tracks devices, as well as back up and stores data in a central location; and LegiAlert that offers messagebroadcasts and alerts, creates groups and contact lists, and integrates contact information with existing back office data systems. The company serves enterprises and educational institutions, as well as consumer, finance and banking, and healthcare industries. LegiTime Technologies, Inc. was founded in 2005 and is based in Farmington, Connecticut.
Show all investments...

Smith & Nephew
VC Fund · London, England, United Kingdom · 2 investments in Israel Medical Device startups

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 5
  • Round size: Series B $2.7M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
  • Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical Device startups, 7 in the past 12 months

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 105
  • Round size: Seed $329k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
  • AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
  • Alomana — Autonomous systems for enterprise
Show all investments...

Eclipse
VC Fund · Palo Alto, California, United States · 2 investments in Israel Medical Device startups

Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.

Show more...

Investment focus

  • Industry: Software, Robotics, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 221
  • Round size: Seed $2.3M–$24M; Series A $9.1M–$55M; Series B $15M–$100M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $510M in 2023

Portfolio highlights

  • Kindred AI — Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platformthat integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.
  • Cerebras Systems — Cerebras is the go-to platform for fast and effortless AI training. Learn more at cerebras.ai.
  • Flex Logix Technologies — Flex Logix charges a license fee for the delivery of the design files and tools, an annual license fee for the ongoing use of the EFLX Compiler for reprogramming, and a royalty. The company was founded in 2014 and is based in Mountain View, California.
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $4M–$55M; Series B $15M–$33M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Show all investments...

ZORA Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Seed $1M–$8.6M; Series A $4M–$8.1M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • Earth Force Technologies — Earth Force is a Vegetation Management System platform.
Show all investments...

Emerge Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

Emerge is an early stage, Tel-Aviv based Venture Capital firm, partnering with exceptional tech-innovators and helping them do whatever it takes to win.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 44
  • Round size: Seed $2.5M–$11M; Series A $5M–$21M; Series B $16M–$80M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Zyg — ZyG is an Operating System for eCom scale, turning great products into successful brands. ZyG's platform is designed to help product inventors and DTC brands validate, scale, and finance their growth, powered by data-driven AI agents
  • Guardio — Protect all your devices online. Keep your personal and business data safe from phishing, malware, and identity theft. Start Guardio's 7-day free trial today.
  • Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
Show all investments...

Zohar Gilon
Angel · 2 investments in Israel Medical Device startups

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

Show more...

Investment focus

  • Industry: Software, Internet, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Hoopo — Hoopo assists companies to boost their logistics operations with cost and power-efficient, LPWA tracking solutions
  • Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
  • Body Vision Medical — Bronchoscopy, reimagined. Using Artificial Intelligence, the Body Vision Platform delivers real-time imaging without the use of electromagnetic sensors.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Health Care, Cyber Security
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 35
  • Round size: Seed $1M–$9M; Series A $1.5M–$9M; Series B $100k–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 2 investments in Israel Medical Device startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 77
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
  • Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Show all investments...

Boston Scientific
VC Fund · Marlborough, Massachusetts, United States · 2 investments in Israel Medical Device startups

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Series B, Series C, Series D
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 54
  • Round size: Series B $3M–$36M; Series C $6M–$27M; Series D $8.3M–$175M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
  • MiRus — MiRus is a medical device company focused on designing innovative solutions for the treatment of spinal and orthopedic degeneration and deformities.
  • 4C Medical Technologies — 4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies that rely on placement and fixation in the native mitral annulus and leftventricle.It was founded in 2015 and headquartered in Maple Grove, Minnesota.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical Device startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
  • Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Show all investments...

The Chartered Group
VC Fund · 2 investments in Israel Medical Device startups

The Chartered Group is an investment platform.

Show more...

Investment focus

  • Industry: Biopharma, Agriculture, Health Care
  • Stage:Series A, Private Equity
  • Geography: Israel

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
  • Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical Device startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $270M in 2021

Portfolio highlights

  • Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
  • Eleos Health — Eleos Health provides AI-powered, highly compliant documentation automation to ease the operational burden on behavioral healthcare providers.
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Show all investments...

Dov Moran
Angel · Kfar Saba, HaMerkaz, Israel · 2 investments in Israel Medical Device startups

Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.

Show more...

Investment focus

  • Industry: Semiconductor, Hardware, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
  • Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
  • Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Show all investments...

Terra Venture Partners
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Israel Medical Device startups

We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies

Show more...

Investment focus

  • Industry: Software, Machine Learning, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2013

Portfolio highlights

  • ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
  • Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
  • Intuition Robotics — The AI care companion robot for older adults
Show all investments...

Laborie Medical Technologies
VC Fund · Mississauga, Ontario, Canada · 2 investments in Israel Medical Device startups

Laborie is a global medical technology company specializing in Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Venture - Series Unknown
  • Geography: United States, Israel

Investor stats

  • Total investments: 8
  • Round size: Series A $26M–$32M; Venture - Series Unknown $11M–$16M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Novocuff — Novocuff is a medical device firm that aims to improve pregnancy outcomes and reduce preterm deliveries caused by PPROM and cervical shortening.
  • Bright Uro — Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.
  • Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Show all investments...

Merz Therapeutics
VC Fund · Frankfurt, Hessen, Germany · 2 investments in Israel Medical Device startups

Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.

Show more...

Investment focus

  • Industry: Health Care, Therapeutics, Medical Device
  • Stage:Corporate Round, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Show all investments...

Chartered Opus
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Israel Medical Device startups

Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.

Show more...

Investment focus

  • Industry: Wellness, Biotechnology, Manufacturing
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Round size: Series A $3M–$3.5M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • SolCold — We make the sun cool again - Solcold the new environment solutions
  • Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Show all investments...

Medical Device Investor funding in Israel at a glance

Stats across 556 deals from 541 investors.

541
investors
in Israel Medical Device startups
556
deals
in Israel Medical Device startups
$5.6M
median round
in Israel Medical Device startups
41%
lead investors
lead at least one round
16%
Seed
most common funding stage
90/10
VC / Angel
share of investor count

Access all 541 investors in Israel Medical Device startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 541 investors investing in Israel Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists